Prior studies have suggested a number of the subjective visual characteristics that help distinguish between spinal meningiomas and schwannomas on magnetic resonance imaging and computed tomography; however, objective quantification of the signal intensity can be useful information. This study assessed whether quantitative magnetic resonance imaging (MRI) signal intensity (SI) measurements could distinguish intradural-extramedullary schwannomas from meningiomas. From July 2019 to September 2021, 54 patients with intradural-extramedullary tumors (37 meningiomas and 17 schwannomas) underwent surgery, and tumors were verified pathologically. Defined regions of interest were used to quantify SI values on T1- (T1W) and T2-weighted images (T2W). Receiver operating characteristic curve analysis was used to obtain cutoff values and calculate the area under the curve (AUC), sensitivity (SE), specificity (SP), positive predictive value (PPV), and negative predictive value (NPV). Both Maximum (T2) and mean (T2) T2W SI values demonstrated outstanding (AUC: 0.91) abilities to differentiate meningiomas from schwannomas with Se, Sp, PPV, and NPV values of 94.6%, 70.6%, 87.5%, and 85.7%, respectively, for T2 and 81.1%, 88.2%, 93.8%, and 68.2% for T2. The maximum SI value on contrast-enhanced T1W (T1CE) and the T2W tumor: fat SI ratio (rTF) demonstrated acceptable abilities (AUC: 0.73 and 0.79, respectively) to differentiate meningiomas from schwannomas with Se, Sp, PPV, and NPV values of 94.6%, 70.6%, 87.5%, and 85.7%, respectively, for T1CE and 81.1%, 88.2%, 93.8%, and 68.2% for rTF. Quantitative SI values (T2, T2 T2, T1CE, rTF) can be used to differentiate intradural-extramedullary schwannomas from meningiomas.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339414 | PMC |
http://dx.doi.org/10.7150/ijms.73319 | DOI Listing |
Oper Neurosurg (Hagerstown)
December 2024
Department of Neurosurgery, Fujita Health University, Toyoake, Aichi, Japan.
Semin Pediatr Neurol
December 2024
Department of Pediatric Neurosciences, University of Texas at Austin, Ascension Dell Children's Medical Center, USA.
Case Rep Pediatr
November 2024
Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
J Neurooncol
November 2024
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Purpose: Meningiomas are central nervous system tumors whose incidence increases with age. Benign meningioma pathogenesis involves germline or somatic mutation of target genes, such as NF2, leading to clonal expansion. We used an established cancer epidemiology model to investigate the number of rate-limiting steps sufficient for benign meningioma development.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!